Back
ESC Premium Access

Randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China

Session: Poster Session 2 - Coronary artery disease epidemiology and outcomes
Topic: Revascularisation
Speaker: Mr J. Du (Beijing, CN)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Mr Junzhe Du

Fuwai Hospital, CAMS and PUMC, Beijing (China)
0 follower

14 more presentations in this session

Impact of intensively lowered low-density lipoprotein cholesterol on lesion prognosis following deferral of revascularization based on fractional flow reserve

Speaker: Doctor S. Nakamura (Tokyo, JP)

Access
Abstract
Like
Thumbnail

Characteristics of patients prescribed Evolocumab in Europe, Does clinical use match clinical guidelines?

Speaker: Professor K. Ray (London, GB)

Access
Abstract
Like
Thumbnail

The effect of combined ezetimibe and statin therapy versus statin therapy alone on coronary plaque volume assessed by intravascular ultrasound: a systematic review and meta-analysis.

Speaker: Doctor P. Thein (London, AU)

Access
Abstract
Slides
Like
Thumbnail

Aortic arch calcifications and inflammation predict in-hospital complications in acute coronary syndrome

Speaker: Doctor D. Terentes-Printzios (Athens, GR)

Access
Abstract
Slides
Like
Thumbnail

German lipoprotein apheresis registry-more than 5 years on

Speaker: Professor V. Schettler (Goettingen, DE)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 2 - Coronary artery disease epidemiology and outcomes

Speakers: Mr J. Du, Doctor S. Nakamura, Professor K. Ray, Doctor P. Thein, Doctor D. Terentes-Printzios...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources